Skip to content

The Naples Pediatric Food Allergy (NAPFA) Score

The Naples Pediatric Food Allergy (NAPFA) Score

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT05707858
Acronym
NAPFA
Enrollment
600
Registered
2023-02-01
Start date
2023-01-23
Completion date
2023-12-20
Last updated
2025-05-14

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Food Allergy in Children

Keywords

Food allergy

Brief summary

Food Allergy (FA) is one of the most expensive allergic disorders in the pediatric age, and affecting up to 10% of children worldwide, it is recognized as a global health problem. The Oral Food Challenge (OFC) is the gold standard for FA diagnosis, but it is time-consuming, expensive, and potentially dangerous, as it can determine severe anaphylaxis. In addition, causing long-lasting impact on patient anxiety and mental health due to the physical duress and health risks involved with its application, OFC strategy is little applied in clinical practice with consequent diagnostic errors and delays. The goal of the Naples Pediatric Food Allergy (NAPFA) score is to develop a new clinical score including the main anamnestic, and clinical features for the easy identification of pediatric FA in primary care setting.

Interventions

OTHERDevelopment of the NAPFA score

In subjects with suspected food allergy we will evaluate main anamnestic, and clinical features to develop the NAPFA score

Sponsors

Federico II University
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
CROSS_SECTIONAL

Eligibility

Sex/Gender
ALL
Age
1 Weeks to 14 Years
Healthy volunteers
No

Inclusion criteria

* subjects aged between 0-14 years with suggestive history of food allergy

Exclusion criteria

*

Design outcomes

Primary

MeasureTime frameDescription
Development of a new clinical score for the identification of pediatric FA in primary care settingat the enrollmentThe score will include the main anamnestic and clinical features

Secondary

MeasureTime frameDescription
Development of a new clinical score for the identification of pediatric FA in secondary and tertiary care settingat the enrollmentThe score will include the main anamnestic and clinical features
Validation of the new clinical NAPFA score for the identification of pediatric FAat the enrollmentValidation of the score on pediatric subject with suspected FA

Countries

Italy

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026